KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Other Non Operating Income (2016 - 2024)

Historic Other Non Operating Income for National Health Investors (NHI) over the last 13 years, with Q4 2024 value amounting to $6.3 million.

  • National Health Investors' Other Non Operating Income changed N/A to $6.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year increase of 475348.84%. This contributed to the annual value of $6.3 million for FY2024, which is 299950.5% up from last year.
  • According to the latest figures from Q4 2024, National Health Investors' Other Non Operating Income is $6.3 million.
  • Over the past 5 years, National Health Investors' Other Non Operating Income peaked at $6.3 million during Q4 2024, and registered a low of -$3.9 million during Q4 2020.
  • Moreover, its 5-year median value for Other Non Operating Income was -$151000.0 (2022), whereas its average is $57571.4.
  • As far as peak fluctuations go, National Health Investors' Other Non Operating Income plummeted by 37679.22% in 2020, and later skyrocketed by 6651.88% in 2022.
  • Over the past 5 years, National Health Investors' Other Non Operating Income (Quarter) stood at -$3.9 million in 2020, then soared by 62.77% to -$1.5 million in 2021, then surged by 89.66% to -$151000.0 in 2022, then surged by 233.77% to $202000.0 in 2023, then soared by 2999.5% to $6.3 million in 2024.
  • Its Other Non Operating Income stands at $6.3 million for Q4 2024, versus $202000.0 for Q3 2023 and -$73000.0 for Q2 2023.